Max Healthcare Institute Limited

NSEI:MAXHEALTH Stok Raporu

Piyasa değeri: ₹958.7b

Max Healthcare Institute Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Max Healthcare Institute kazançlarla iyi bir şekilde karşılanan, 0.15% cari getiriye sahip, temettü ödeyen bir şirkettir.

Anahtar bilgiler

0.1%

Temettü verimi

-0.0004%

Geri Alım Getirisi

Toplam Hissedar Getirisi0.1%
Gelecekteki Temettü Verimi0.2%
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettü₹1.500
Ödeme oranı14%

Son temettü ve geri alım güncellemeleri

Recent updates

Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Nov 09
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Sep 14
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Jul 18
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Jun 21
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

May 25
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Apr 14
Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Mar 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 03
Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Jan 08
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

Dec 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Oct 26
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Sep 20
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Jul 07
Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Jun 19
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

Apr 11
Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Mar 15
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Feb 22
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Nov 22
Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Oct 26
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Jul 15
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Mar 09
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

Nov 24
Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: MAXHEALTH 'un temettü ödemelerinin istikrarlı olup olmadığını söylemek için henüz çok erken, zira şirket henüz temettü ödemeye başladı.

Büyüyen Temettü: MAXHEALTH 'un temettü ödemelerinin artıp artmadığını söylemek için henüz çok erken, zira şirket henüz temettü ödemeye başladı.


Piyasaya Karşı Temettü Getirisi

Max Healthcare Institute Piyasaya Karşı Temettü Getirisi
MAXHEALTH temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (MAXHEALTH)0.1%
Pazarın Alt %25'i (IN)0.2%
Pazarın En İyi %25'i (IN)1.1%
Sektör Ortalaması (Healthcare)0.3%
Analist tahmini (MAXHEALTH) (3 yıla kadar)0.2%

Önemli Temettü: MAXHEALTH şirketinin temettüsü ( 0.15% ), Indian pazarındaki temettü ödeyenlerin en alttaki %25'ine ( 0.25% ) kıyasla dikkate değer değil.

Yüksek Temettü: MAXHEALTH 'in temettüsü ( 0.15% ), Indian piyasasındaki temettü ödeyenlerin en üst %25'ine ( 1.13% ) kıyasla düşüktür.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Düşük ödeme oranı ( 13.8% ) sayesinde MAXHEALTH 'un temettü ödemeleri kazançlarla tamamen karşılanmaktadır.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Makul nakit ödeme oranı ( 55% ) ile MAXHEALTH 'un temettü ödemeleri nakit akışları ile karşılanmaktadır.


Güçlü temettü ödeyen şirketleri keşfedin